After the Storm

In order to prepare for any potential future crises, we must understand and learn from our current experiences. We appreciate this opportunity to get your feedback. Your opinion matters, and collectively, we can enact positive change in our healthcare industry.

read more

#ItsMyTurn: IgNS Plasma Donation Initiative

During this unprecedented time of fear and uncertainty, we witness daily the incredible sacrifices of healthcare professionals, EMS, military, law enforcement, and others working tirelessly to keep patients healthy and save lives. We have witnessed people coming...

read more

IgNS COVID-19 Resource Guide & FAQ

IgNS places the utmost importance on maintaining the health and safety of patients and healthcare providers during this COVID-19 global pandemic.  IgNS has compiled relevant guidance to support clinicians and patients through the complexities of managing Ig patients...

read more

Good news: R&D Progress Report on COVID-19

Coronavirus vaccine trial administers first doses to participants A Phase 1 clinical trial evaluating an investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) has begun at Kaiser Permanente Washington Health Research Institute...

read more

Important IgNS Update (3/17/2020)

Dear Colleagues, IgNS is closely following the developments regarding the COVID-19 pandemic. This is a rapidly evolving situation, with information and guidance updated on an ongoing basis to reflect the most recent recommendations. Please check for updates from the...

read more

COVID-19 Update

COVID-19 Update IgNS thanks all healthcare professionals and service providers, first responders, government agencies, and the healthcare industry who are working tirelessly in the face of the COVID-19 pandemic.  Roche receives emergency approval for COVID-19...

read more

USP Delaying Standards Implementation Dates

On Sept. 23, the Healthcare Quality and Safety team at USP issued a letter announcing that it would delay the planned Dec. 1 implementation of three of its chapters: the revised <795> Pharmaceutical Compounding—Nonsterile Preparations and <797>...

read more

Examining the Application of Ig in Multiple Disease States

Examining the Application of Immunoglobulin in Multiple Disease States: A Review of Evidence Activity Overview: The administration of immunoglobulin (Ig) has become common practice in the treatment of patients with immunodeficiencies, and, more recently, in other...

read more

Stay In The Know

Join to receive important new, updates, and announcements.

Subscribe to our mailing list

* indicates required

© IgNS Copyright 2023 - All Rights Reserved

© IgNS Copyright 2023 - All Rights Reserved